Examples of 'renal impairment creatinine clearance' in a sentence
Meaning of "renal impairment creatinine clearance"
Renal impairment creatinine clearance refers to a medical term used to assess the functioning of the kidneys. It involves measuring the creatinine levels in the blood to determine the efficiency of the kidneys in filtering waste products. Renal impairment signifies a reduction in kidney function, while creatinine clearance measures the volume of blood cleared of creatinine per unit of time, indicating kidney health
How to use "renal impairment creatinine clearance" in a sentence
Basic
Advanced
renal impairment creatinine clearance
In patients with moderate renal impairment creatinine clearance.
Since sildenafil clearance is reduced in patients with severe renal impairment creatinine clearance.
In patients with severe renal impairment creatinine clearance below 30 ml / min.
There is limited experience with ambrisentan in individuals with severe renal impairment creatinine clearance.
Moderate or severe renal impairment creatinine clearance less than or equal to 50 mL / minute.
Fampyra should not be administered to patients with renal impairment creatinine clearance.
Patients with severe renal impairment creatinine clearance < 30 mL / min.
Siklos should not be administered to patients with severe renal impairment creatinine clearance.
In patients with severe renal impairment creatinine clearance.
Ifirmacombi should not be used in patients with severe renal impairment creatinine clearance.
Table 1, dosage adjustment in renal impairment creatinine clearance ( ml / min ).
A dose adjustment is required for patients with severe renal impairment creatinine clearance.
Adult patients with severe renal impairment creatinine clearance of.
Levviax is not recommended as first choice in patients with severe renal impairment creatinine clearance.
Patients with moderate or severe renal impairment creatinine clearance < 50 ml / min.
See also
Ketek is not recommended as first choice in patients with severe renal impairment creatinine clearance.
Use of Zavesca in patients with severe renal impairment creatinine clearance.
LITAK is contraindicated in patients with moderate to severe renal impairment creatinine clearance.
AVAGLIM is contraindicated in patients with severe renal impairment creatinine clearance less than.
The recommended start dose is 5 mg in patients with moderate renal impairment creatinine clearance.
There is no pharmacokinetic data in patients with severe renal impairment creatinine clearance below 30 ml / min.
No dose adjustment is necessary in patients with mild renal impairment creatinine clearance.
Tolucombi should not be used in patients with severe renal impairment creatinine clearance.
Incresync is not recommended for patients with severe renal impairment creatinine clearance.
No dose adjustment is necessary for patients with mild renal impairment creatinine clearance.
No dose adjustment is needed for patients with mild renal impairment creatinine clearance CrCl.
In adult or paediatric patients with moderate and severe renal impairment creatinine clearance less than.
Actelsar HCT should not be used in patients with severe renal impairment creatinine clearance.
No dosage reduction is required for patients with mild renal impairment creatinine clearance M.
Table 1, Recommended dosage schedule for patients with renal impairment Creatinine clearance.
No dose adjustment is recommended for mild to moderate renal impairment creatinine clearance > 30 ml / min.
There is no therapeutic experience in patients with severe renal impairment creatinine clearance below 30 ml / min.
No dosage reduction is required for patients with mild renal impairment creatinine clearance > 50 ml / min.
Dose adjustment is therefore not required in patients with renal impairment creatinine clearance > 10 ml / min.
There are limited pharmacokinetic data in patients with severe renal impairment creatinine clearance < 30 ml / min.
Eviplera is not recommended for patients with moderate or severe renal impairment creatinine clearance < 50 mL / min.
Atripla is not recommended for patients with moderate or severe renal impairment creatinine clearance < 50 ml / min.
Quinsair is not recommended for use in patients with severe renal impairment creatinine clearance ˂ 20 ml / min.
TREVICTA is not recommended in patients with moderate or severe renal impairment creatinine clearance < 50 ml / min.
No dosage adjustment is necessary in patients with mild renal impairment creatinine clearance 50 - 80 ml / min.
Patients with renal impairment Mild or moderate renal impairment creatinine clearance 30 to 80 ml / min.
Severe hepatic impairment ( Child-Pugh classification C ) or severe renal impairment creatinine clearance < 30 ml / min.
You'll also be interested in:
Examples of using Renal
Show more
He had some renal issues last year
Renal perfusion and circulation time are reduced
The kid had a renal artery thrombosis
Examples of using Creatinine
Show more
His creatinine level is almost high normal
Serial measurements of serum creatinine levels were performed
Creatinine increases were comparable by various background regimens
Examples of using Clearance
Show more
Clearance of the annual report on technical cooperation
I got special clearance through gate four
Clearance from countertop to unprotected overhead surface
Examples of using Impairment
Show more
An impairment test is realized during each closing
You have a neurological impairment called somatoparaphrenia
Impairment testing is done at the individual investment level
